PATENT CLAIM ANALYSIS

Application Number: 15863132
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "468000"]

Abstract:
The invention provides naphthofuran compounds, polymorphs of naphthofuran compounds, naphthofuran compounds in particle form, purified compositions that contain one or more naphthofuran compounds, purified compositions that contain one or more naphthofuran compounds in particle form, methods of producing these naphthofuran compounds, polymorphs, purified compositions and/or particle forms, and methods of using these naphthofuran compounds, polymorphs, purified compositions and/or particle forms to treat subjects in need thereof.

Claim (Index 14):
The method of  claim 13 , wherein the cancer is selected from the group consisting of colorectal adenocarcinoma, breast cancer, ovarian cancer, head and neck cancer, melanoma, angiosarcoma, gastric adenocarcinoma, lung cancer, refractory cancer, recurrent cancer, metastatic cancer, and adrenocorticoid.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 2.48387
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14642931', '13634694', '13634676', '12677513', '14002986']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7871107117294707
- 35 USC 102 Novelty (BERT): 0.605024702912649
- Combined Prediction Score: 0.7689021108477885
- Mean Citation Score: 417.440162
- Max Citation Score: 543.513
- Similarity Product: 462.2136117550135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test